What Is the Value of PCR Testing in COVID-19 Diagnosis?
The use of a PCR test via single nasopharyngeal swab to diagnose SARS-CoV-2 has value but also has demonstrated limitations.
All articles by Zahra Masoud
COVID-19: High Through-Put Antibody Assay May Be More Efficient in Diagnosing SARS-CoV-2
A high through-put Luminex antibody assay may provide more accurate results in less time, increasing the efficiency of SARS-CoV-2 diagnosis.
COVID-19: SARS-CoV-2 Transmission Probable Through Fecal Aerosols
A case of COVID-19 transmission in a high-rise apartment complex in China demonstrates the probable transmission of SARS-CoV-2 through fecal aerosols.
Reducing COVID-19 Spread: Quarantine vs Active Monitoring of Contacts
Considering the impact quarantine has on resources and individual liberty, it is important to evaluate under what conditions individual quarantine can more effectively control COVID-19 than active monitoring.
Icatibant Treatment Improves Oxygenation in COVID-19 Patients
Icatibant, a bradykinin 2 receptor antagonist, may improve oxygenation in patients with coronavirus disease 2019 (COVID-19).
COVID-19: Influenza Vaccine Key in Mitigating Healthcare Burden During Flu Season
During the upcoming flu season, it is essential to ensure a high coverage rate of vaccination, particularly among populations who are vulnerable to COVID-19.
COVID-19: Seasonality of Coronaviruses May Provide Insight for Future SARS-CoV-2 Circulation
Following the initial pandemic wave of SARS-CoV-2 infections, it is unclear what trajectory of transition SARS-CoV-2 might take.
COVID-19: Utility of Antibiotic Therapy for Nosocomial Coinfection Unclear
Patients with COVID-19 who are admitted to the ICU may experience higher rates of coinfections requiring antibiotic therapy compared with non-ICU patients.
Invasive Aspergillosis Superinfection Possible in Symptomatic COVID-19
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
Comparison Finds Rifampin Superior in Cost, Safety to Isoniazid for Latent Tuberculosis
A shorter regimen of rifampin is safer and less expensive than the standard 9-month regimen of isoniazid for treatment latent tuberculosis.
-
Loading...
-
Loading...
Next post in Tuberculosis
